Overview
Oxford-based biotech startup Scripta Therapeutics has raised €10.3 million ($12 million) in a seed funding round led by Oxford Science Enterprises and Apollo Health Ventures. The company aims to revolutionize drug discovery for neurodegenerative diseases by targeting transcription factors, potentially halting disease progression.
Products
Loading...
Recent Deals
Investors: Oxford Science Enterprises, Apollo Health Ventures
Oxford-based biotech startup Scripta Therapeutics has raised €10.3 million ($12 million) in a seed funding round led by Oxford Science Enterprises and Apollo Health Ventures. The company aims to revolutionize drug discovery for neurodegenerative diseases by targeting transcription factors, potentially halting disease progression.